Infinity Pharmaceuticals: Q1 Earnings Insights

Infinity Pharmaceuticals INFI reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Infinity Pharmaceuticals missed estimated earnings by 7.69%, reporting an EPS of $-0.14 versus an estimate of $-0.13.

Revenue was up $185.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 13.53% increase in the share price the next day.

Here's a look at Infinity Pharmaceuticals's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.13 -0.13 -0.14 -0.12
EPS Actual -0.13 -0.12 -0.13 -0.15
Revenue Estimate 300.00K 520.00K 280.00K 1.15M
Revenue Actual 451.00K 428.00K 512.00K 467.00K

To track all earnings releases for Infinity Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!